K-numberK243234
Device nameSecond Opinion® CS
ApplicantPearl, Inc.
Product codeMYN
Device classClass II
Decision dateJun 12, 2025
DecisionSubstantially Equivalent
Regulation892.2070
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Second Opinion® CS is computer-aided detection (CADe) software designed to help dental professionals detect and segment caries (cavities) in periapical radiographs of permanent teeth in patients 12 years and older. The software uses machine learning to identify suspected carious lesions and overlay them on the original radiograph, providing a detailed analysis showing the percentage overlap of the lesion with dentin and enamel.

Technological characteristics

The device uses neural network-based computer vision algorithms developed with supervised machine learning to process digital intraoral radiographs on Windows operating systems. It demarcates detections within a user interface with graphical overlays and produces near-instantaneous detection results. The key distinction from the primary predicate is that Second Opinion CS adds caries lesion anatomical segmentation (enamel and dentin percentages), whereas the original Second Opinion did not include segmentation.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

Second Opinion CS is substantially equivalent because it maintains the same intended use as the predicate devices—aiding dentists in caries detection in periapical radiographs using CADe software with machine learning. The clinical evidence demonstrates comparable or superior performance: the standalone study showed 88% sensitivity in caries detection, and the MRMC study demonstrated statistically significant improvement in aided reader performance (wAFROC-FOM difference: 0.05, p=0.0345) with reliable segmentation accuracy. The addition of segmentation analysis (enamel/dentin percentages) represents an enhancement to the same fundamental technology and intended use, raising no new safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →